MeSH D013923 - thromboembolism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Argatroban | Argatroban |  | 2014-12-15 |  |  |
| Taro Pharmaceutical | Warfarin | Warfarin |  | 1999-07-15 |  |  |
| LEO Pharma | Tinzaparin | Innohep |  | 2000-07-14 |  |  |
| Mylan | Argatroban | Argatroban |  | 2014-06-30 |  |  |
| Heparin sodium | Heparin |  | 2017-11-30 |  |  | |
| Cipla | Argatroban | Argatroban | 2027-09-26 | 2011-06-29 |  |  |
| Warfarin | Warfarin |  | 2011-05-25 |  |  | |
| Sandoz | Argatroban | Argatroban |  | 2000-06-30 |  |  |
| Enoxaparin | Enoxaparin |  | 2010-07-23 |  |  | |
| Heparin sodium | Heparin |  | 2011-06-08 |  |  | |
| Aspen Global | Heparin | Liquaemin |  | 1982-01-01 |  |  |
| Danaparoid | Orgaran |  | 1996-12-24 |  |  | |
| Organon | Phenprocoumon | Liquamar |  | 1982-01-01 |  |  |
| Novartis | Heparin, Lidocaine, Dihydroergotamine | Embolex |  | 1984-11-30 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
25%1/4
Phase 2
48%13/27
Phase 3
77%20/26
Approved: 11Overall Success rate: 9%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use